Aridis Pharmaceuticals Inc

NASDAQ:ARDS   3:59:51 PM EDT
3.37
+0.08 (+2.43%)
Earnings Announcements

Aridis Pharmaceuticals Reports Q4 Loss Per Share $0.59

Published: 03/30/2021 22:09 GMT
Aridis Pharmaceuticals Inc (ARDS) - Aridis Pharmaceuticals Announces 2020 Fourth Quarter and Year-end Financial Results and Business Update.
Q4 Loss per Share $0.59.
Q4 Earnings per Share Estimate $-0.59 -- Refinitiv Ibes Data (analyst estimates).
Q4 Revenue $1.0 Million.
Q4 Revenue Estimate $500,000 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.45 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $1.6 Million
Next Quarter EPS Guidance is expected to be -$0.49

More details on our Analysts Page.